RE: “An Estimation of the Risk of Pseudotumor Cerebri Among Users of the Levonorgestrel Intrauterine Device”

ABSTRACT

The current letter to the editor describes some of the limitations of Valenzuela et al.’s study on the association between levonorgestrel-releasing intrauterine system use and pseudotumor cerebri/idiopathic intracranial hypertension and further reinforces the authors’ interpretations of the findings.

Keywords:

• Pseudotumor cerebri
• idiopathic intracranial hypertension
• levonorgestrel intrauterine system
• contraception
• prevalence

Conflict of interest

AG and JSch were both employees of Bayer AG.

Additional information

Funding

This study was supported by Bayer AG.